{"id":"https://openalex.org/W190640570","doi":null,"title":"Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.","display_name":"Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-04-01","ids":{"openalex":"https://openalex.org/W190640570","mag":"190640570","pmid":"https://pubmed.ncbi.nlm.nih.gov/16673799"},"language":"en","primary_location":{"id":"pmid:16673799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16673799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W190640570"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068989339","display_name":"Philippe Andr\u00e8s","orcid":"https://orcid.org/0000-0003-4706-8099","observed_orcids":["https://orcid.org/0000-0003-4706-8099"]},"institutions":[{"id":"https://openalex.org/I4210120458","display_name":"Galderma (France)","ror":"https://ror.org/034kxvk28","country_code":"FR","type":"company","lineage":["https://openalex.org/I4210120458","https://openalex.org/I4210163806"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philippe Andres","raw_affiliation_strings":["Galderma R&D, Sophia Antipolis, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Galderma R&D, Sophia Antipolis, France","institution_ids":["https://openalex.org/I4210120458"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michel Poncet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michel Poncet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045634965","display_name":"Farzaneh Sidou","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sidou Farzaneh","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5049256929","display_name":"Pascale Soto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pascale Soto","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6575,"has_fulltext":false,"cited_by_count":39,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.6473768,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":97},"biblio":{"volume":"5","issue":"4","first_page":"328","last_page":"332"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.9550999999046326,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.03590000048279762,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clobetasol-propionate","display_name":"clobetasol propionate","score":0.9980000257492065},{"id":"https://openalex.org/keywords/scalp-psoriasis","display_name":"scalp psoriasis","score":0.8759999871253967},{"id":"https://openalex.org/keywords/topical-corticosteroids","display_name":"topical corticosteroids","score":0.8479999899864197},{"id":"https://openalex.org/keywords/shampoo-formulation","display_name":"shampoo formulation","score":0.7289999723434448},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-adrenal-axis-suppression","display_name":"hypothalamic-pituitary-adrenal axis suppression","score":0.9710000157356262},{"id":"https://openalex.org/keywords/skin-atrophy","display_name":"skin atrophy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/eye-safety","display_name":"eye safety","score":0.9629999995231628},{"id":"https://openalex.org/keywords/corticosteroid-side-effects","display_name":"corticosteroid adverse effects","score":0.7279999852180481},{"id":"https://openalex.org/keywords/skin-thickness","display_name":"skin thickness","score":0.527999997138977}],"concepts":[{"id":"https://openalex.org/C2776110085","wikidata":"https://www.wikidata.org/wiki/Q421637","display_name":"Clobetasol propionate","level":3,"score":0.9755927324295044},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8497012257575989},{"id":"https://openalex.org/C2781171460","wikidata":"https://www.wikidata.org/wiki/Q180204","display_name":"Shampoo","level":2,"score":0.7476726770401001},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6962056756019592},{"id":"https://openalex.org/C2778515351","wikidata":"https://www.wikidata.org/wiki/Q9622","display_name":"Scalp","level":2,"score":0.6881236433982849},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6732302904129028},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.6328287720680237},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.42067164182662964},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.38425442576408386},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2657703161239624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23327794671058655},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09488475322723389}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001284","descriptor_name":"Atrophy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D002990","descriptor_name":"Clobetasol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002990","descriptor_name":"Clobetasol","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002990","descriptor_name":"Clobetasol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D002990","descriptor_name":"Clobetasol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006203","descriptor_name":"Hair Preparations","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007030","descriptor_name":"Hypothalamo-Hypophyseal System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D007030","descriptor_name":"Hypothalamo-Hypophyseal System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009799","descriptor_name":"Ocular Physiological Phenomena","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010913","descriptor_name":"Pituitary-Adrenal System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010913","descriptor_name":"Pituitary-Adrenal System","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012536","descriptor_name":"Scalp Dermatoses","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D012867","descriptor_name":"Skin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:16673799","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16673799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:190640570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16673799","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4237722028","https://openalex.org/W523050","https://openalex.org/W2031409726","https://openalex.org/W3193812210","https://openalex.org/W152437768","https://openalex.org/W3214186490","https://openalex.org/W4241170151","https://openalex.org/W198214931","https://openalex.org/W2753317816","https://openalex.org/W1994129835"],"abstract_inverted_index":{"Clobetasol":[0],"propionate":[1,55,74,88,95,138],"is":[2,15],"known":[3],"to":[4,42,76,100,105,112,144],"be":[5,77],"a":[6,85,117],"very":[7],"effective":[8],"treatment":[9],"for":[10,69],"psoriasis;":[11],"however,":[12],"its":[13],"use":[14],"limited":[16],"by":[17],"potent":[18],"corticosteroid":[19],"class":[20],"related":[21],"side":[22],"effects":[23],"such":[24],"as":[25],"hypothalamic-pituitary-adrenal":[26],"(HPA)":[27],"axis":[28,46,102,114],"suppression":[29,47,103,115],"and":[30,50,116],"atrophogenicity.":[31],"The":[32,90],"aim":[33],"of":[34,53],"this":[35],"single-center,":[36],"parallel":[37],"group,":[38],"randomized":[39],"study":[40,91],"was":[41],"assess":[43],"the":[44,109,131,136,145],"HPA":[45,101,113],"potential,":[48],"atrophogenicity,":[49],"ocular":[51,128],"tolerability":[52],"clobetasol":[54,73,87,94,137],"shampoo":[56,96,139],"in":[57,119],"26":[58],"patients":[59],"with":[60,72,84],"scalp":[61],"psoriasis.":[62],"Suitable":[63],"subjects":[64],"were":[65],"treated":[66],"once":[67],"daily":[68],"4":[70],"weeks":[71],"shampoo,":[75],"rinsed":[78],"off":[79],"after":[80],"15":[81],"minutes":[82],"or":[83,104],"leave-on":[86],"gel.":[89,146],"demonstrated":[92],"that":[93],"did":[97],"not":[98],"lead":[99],"skin":[106,120],"atrophy.":[107],"Conversely,":[108],"gel":[110],"led":[111],"decrease":[118],"thickness.":[121],"Neither":[122],"formulation":[123],"had":[124],"an":[125],"impact":[126],"on":[127],"safety.":[129],"Despite":[130],"short":[132],"contact":[133],"application":[134],"time,":[135],"provides":[140],"similar":[141],"efficacy":[142],"results":[143]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W190640570","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
